- Shop Products
- Services & Tools
- Business Resources
- Clinical Resources
- About Us
- Contact Us
Did you know that 1 in 10 American adults have osteoarthritis (OA)¹? That’s roughly 30.8 million people and by 2024 it’s projected that the number of doctor-diagnosed OA will increase to 26%² of all Americans. Due to this rising demand, the number of hyaluronic acid (HA) joint injection treatments has increased in recent years.
The Food and Drug Administration (FDA) has approved various products, creating a broad portfolio of injection treatments with relative different options, such as:
When it comes to specialty pharmaceuticals and devices, you need support, reliability and speed. Our integrated approach to procurement puts you in control so that your centralized purchasing program becomes budget savvy and easier for your practice to manage.
We have an easy 1-2-3 step process to get you up and running:
If you already have a McKesson Medical-Surgical Account Manager working with your account, this information will be sent to them.